Skip to main content

Day: September 21, 2021

Immutep to Present Final Overall Survival Data From Phase IIb AIPAC as a Late Breaking Poster Presentation at SITC 2021

SYDNEY, Australia, Sept. 21, 2021 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune disease, is pleased to announce it will report final Overall Survival (OS) data from its Phase IIb AIPAC clinical trial evaluating lead product candidate eftilagimod alpha (“efti” or “IMP321”) in metastatic breast cancer at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2021. SITC 2021 is taking place in Washington, US and virtually from 10-14 November. The final OS data will be presented by Immutep at SITC 2021 as a late breaker poster presentation. Interim OS data from the trial was presented in a spotlight presentation at the San Antonio Breast Cancer Symposium in December 2020. Immutep...

Continue reading

Evaxion Biotech Appoints Dr. Birgitte Rønø as Chief Scientific Officer

Dr. Rønø has developed Evaxion’s pre-clinical and early clinical oncology pipeline Newly-created Chief Scientific Officer role strengthens Evaxion’s leadership teamCOPENHAGEN, Denmark, Sept. 21, 2021 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer, bacterial diseases and viral infections, announced today it has promoted its Senior Director, Immuno-Oncology, Birgitte Rønø, Ph.D, to the newly-created position of Chief Scientific Officer, effective immediately. Lars Wegner, CEO of Evaxion, said: “As Senior Director of Evaxion’s Cancer Immunotherapy, Birgitte Rønø played a critical role in the development of Evaxion’s pre-clinical...

Continue reading

Hill International Receives Five-Year IDIQ Contract to Continue Providing CMI Services to the Maryland Aviation Administration

PHILADELPHIA and BALTIMORE, Sept. 21, 2021 (GLOBE NEWSWIRE) — Hill International (NYSE:HIL), delivering the infrastructure of change, announced today it was awarded an indefinite delivery/indefinite quantity contract to provide construction management and inspection (CMI) services to the Maryland Aviation Administration (MAA) until 2026. Hill has been providing CMI support for airside, landside, and terminal projects at Baltimore/Washington Thurgood Marshall Airport (BWI) and Martin State Airport (MTN) since 2015. The Hill team has developed strong working relationships throughout the MAA organization and leverages these relationships to facilitate project delivery. The team has also internalized the processes, procedures, and standards governing all MAA’s construction programs. This includes a commitment to incorporating local...

Continue reading

DARPA Researchers Can Now Accelerate Technology Innovation Using Microchip’s Low-Power FPGA Product Families

Company joins the defense agency’s innovation initiative that gives its researchers greater, more simplified access to commercial technologies and tools CHANDLER, Ariz., Sept. 21, 2021 (GLOBE NEWSWIRE) — Microchip Technology Inc. (Nasdaq: MCHP) today announced it has joined the Defense Advanced Research Projects Agency (DARPA) Toolbox initiative that gives the organization’s researchers simplified open licensing opportunities with commercial technology vendors. Microchip’s participation will speed innovation across a variety of defense and aerospace development programs by giving qualified DARPA researchers zero-cost access to the company’s Libero® design software suite and associated intellectual property (IP) for developing systems based on its low-power FPGA product families. “As the industry’s largest microelectronics suppliers...

Continue reading

Executive Management Change

Executive Management Change AMSTERDAM, September 21, 2021 – Stellantis N.V. (NYSE / MTA / Euronext Paris: STLA) (“Stellantis”) announces that Mike Manley will step down from his role as Head of Americas for Stellantis to take up the role of CEO at AutoNation Inc, America’s largest automotive retailer based in Florida, from November 1, 2021. Mark Stewart (Chief Operating Officer, North America) and Antonio Filosa (Chief Operating Officer, Latin America), the Top Executive Team members with responsibility for the North American and Latin American regions, will henceforward report directly to Chief Executive Officer Carlos Tavares. Carlos Tavares said: “It’s been my privilege to know Mike first as a competitor, then as a partner and colleague in the creation of Stellantis, but most importantly, always as a friend. From the very earliest days...

Continue reading

Outlook Therapeutics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference

Live fireside chat with C. Russell Trenary, President and CEO of Outlook Therapeutics on Tuesday, September 28 at 2:00 PM ET ISELIN, N.J., Sept. 21, 2021 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today announced that C. Russell Trenary, President and Chief Executive Officer of Outlook Therapeutics, will participate in a fireside chat hosted by Kristen Kluska, Director, Equity Research at the Cantor Fitzgerald Virtual Global Healthcare Conference on Tuesday, September 28, 2021 at 2:00 PM ET. In addition to the fireside chat, management will be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered...

Continue reading

Eco Innovation Announces Retirement of Variable Convertible Debt

VAN NUYS, Calif., Sept. 21, 2021 (GLOBE NEWSWIRE) — Eco Innovation Group, Inc. (OTC: ECOX) (“ECOX” or the “Company”), an innovative company aggregating investments in new technologies that promote environmental and social well-being and the advancement of green energy solutions, is proud to announce that it has now retired all remaining outstanding variable rate convertible debt from its balance sheet. This preemptive step follows similar steps taken over the summer as well as the Company’s pledge to retire remaining convertible notes and pursue non-dilutive future financing strategies. “In June, we noted we were actively pursuing a strategy to defend our shareholder friendly corporate ideal by eliminating potential sources of dilution,” noted ECOX CEO Julia Otey-Raudes. “We eliminated a large tranche of...

Continue reading

HP Brings You Closer to the People and Things You Love with New Windows 11 Devices

Purposeful features include adjustable cameras to connect easily with family and friends, HP GlamCam to make you look and feel your best on video calls, and HP Palette – a digital workspace software to simplify the creative processNews Highlight: HP Spectre x360 16 inch 2-in-1 Laptop PCPresent your best self with the HP Spectre x360 16 inch 2-in-1 Laptop PC, featuring a 5 MP IR camera, smart features that keep you in-frame and well-lit, and is the first HP consumer notebook made with recycled CNC aluminum.News Highlight: HP ENVY 34 inch All-in-One Desktop PCDesigned for creators by creators, the HP ENVY 34 inch All-in-One Desktop PC offers true-to-life color and a detachable magnetic camera for better angles or sharing sketches on your workspace.News Highlight: HP 11 inch Tablet PCExperience...

Continue reading

LifeMD to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference

NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) — LifeMD, Inc. (“the Company”) (NASDAQ: LFMD) a rapidly growing direct-to-patient telehealth company that offers cash pay virtual medical treatment, prescription medications, and over the counter products to patients across all 50 states today announced that management will present at the Cantor Fitzgerald Virtual Global Healthcare Conference. Details for the presentation are below:   Date: Thursday, September 30th, 2021Time: 12:40 pm ETWebcast: https://wsw.com/webcast/cantor12/lfmd/2065630   Management will also be available for virtual one-on-one meetings. To request a meeting, please contact corporateaccess@cantor.com. About LifeMDLifeMD, Inc. is a rapidly growing direct-to-patient telehealth company that offers cash pay virtual medical treatment, prescription medications...

Continue reading

Current Water Technologies Inc. Enters New Market – Signs Memorandum of Understanding With Leading Consortium of Aquaculture Companies

GUELPH, Ontario, Sept. 21, 2021 (GLOBE NEWSWIRE) — Current Water Technologies Inc. (TSX-V: WATR) (“CWTI” or “the Company” or “the Corporation”), an emerging technology leader in the management of industrial and municipal wastewater and drinking water resources, announced today that the Company has executed a Memorandum of Understanding (MOU) with a consortium of aquaculture companies collectively operating under the newly incorporated Canadian company, Ship Nature’s Way Inc. (SNW). A Definitive Collaboration Agreement with Ship Nature’s Way will be signed within the next 60 days. The global aquaculture market was valued at approximately USD230 billion in 2020, and the market is projected to grow to approximately USD340 billion in 2027, based on a predicted compound annual growth rate (CAGR) of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.